Composition
- Active ingredients
- GLYCOPYRROLATE 15.6MCG/INH
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA207923.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Seebri Neohaler
- Active substance
- glycopyrrolate
- Route
- Inhalation
- Dosage form
- Powder
- Applicant
- Novartis
- Status
- Discontinued
- FDA approval
- 29 Oct 2015
- Application
- NDA207923-001